Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Cassava Sciences Stock Skyrocketed 145.1% in February

TheMotleyFool

0 0

Why Cassava Sciences Stock Skyrocketed 145.1% in February

Shares of Cassava Sciences (NASDAQ: SAVA) jumped 145.1% in February, according to data from S&P Global Market Intelligence. Progress on the company's experimental drug treatment for Alzheimer's has driven incredible gains for the stock.